Cargando…

A clinical review of GLP-1 receptor agonists: efficacy and safety in diabetes and beyond

The prevalence of type 2 diabetes is increasing at an astounding rate. Many of the agents used to treat type 2 diabetes have undesirable adverse effects of hypoglycemia and weight gain. Glucagon-like peptide-1 (GLP-1) receptor agonists represent a unique approach to the treatment of diabetes, with b...

Descripción completa

Detalles Bibliográficos
Autores principales: Prasad-Reddy, Lalita, Isaacs, Diana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Just Medical Media Limited 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4509428/
https://www.ncbi.nlm.nih.gov/pubmed/26213556
http://dx.doi.org/10.7573/dic.212283